ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Dolutegravir sodium
C20H18F2N3NaO5
441.4 g/mol
APIWarning

DOLUTEGRAVIR SODIUM

CAS1051375-19-9
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material

Dolutegravir sodium is an organic sodium salt and the monosodium salt form of dolutegravir. It is a pharmaceutical raw material used in the manufacturing of HIV-1 integrase inhibitor-based therapies.

Active pharmaceutical ingredient for HIV-1 integrase inhibitor drug productsRaw material for combination antiretroviral therapies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 1051375-19-9

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

SimilarStructure SimilarSimilarity 0.80

(4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide

CAS1335210-35-9

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.75

Dolutegravir o-benzyl impurity

CAS1206102-11-5

pharmaceutical raw material

ReferenceSame Category

7-methyl-2-(2,2,3,3-tetradeuteriocyclopropyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one

CAS1051418-95-1

pharmaceutical raw material

ReferenceSame Category

Tetrabutylammonium acetate

CAS10534-59-5

pharmaceutical raw material

ReferenceSame Category

Ne-58018

CAS105462-23-5

pharmaceutical raw material

ReferenceSame Category

Risedronic acid

CAS105462-24-6

pharmaceutical raw material

Referencestereoisomer of

2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4S,12aR)-

CAS1309560-49-3

pharmaceutical raw material

Referencestereoisomer of

4-epi-Dolutegravir

CAS1357289-29-2

pharmaceutical raw material

Safety Reference

Harmful
Harmful
Environmental Hazard
Environmental Hazard
Warning
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
H302Harmful if swallowed
Identifiers
IUPAC Name

sodium (3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate

InChIKey

UGWJRRXTMKRYNK-VSLILLSYSA-M

SMILES

C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]

Synonyms (13)
  • Dolutegravir sodium (JAN/USAN)
  • DOLUTEGRAVIR SODIUM
  • Dolutegravir sodium salt
  • Dovato
  • GSK 1349572A
  • GSK1349572 sodiuM salt
  • GSK1349572 sodium
  • TIVICAY PD
  • Tivicay
  • Tivicay (TN)